Which ETFs hold Novartis AG (NOVN)?
Swiss pharmaceutical company making medicines for heart disease, cancer and immune conditions.
37 Australian ETFs hold Novartis AG, a Health Care company from Switzerland. DRUG has the biggest weighting at 3.93%. Across these funds, Australian ETF investors own about $510m of Novartis AG.
The ETFs with the most Novartis AG
All 37 ETFs that hold Novartis AG, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Novartis AG.
Common questions
Which ETF has the most Novartis AG?
DRUG (Betashares Global Healthcare Currency Hedged ETF) has the highest weighting, with 3.93% of the fund in Novartis AG.
What is the cheapest ETF that holds Novartis AG?
Of the ETFs where Novartis AG is at least 1% of the fund, EXUS has the lowest fee at 0.14% a year, with 1.24% in Novartis AG.
How much Novartis AG do I own with $10,000 in VGS?
About $29. VGS is the largest ETF that holds Novartis AG, and Novartis AG makes up 0.29% of it.
How many Australian ETFs hold Novartis AG?
37 ETFs listed on the ASX or TMX Australia hold Novartis AG, based on issuers' published holdings.